Breaking Finance News

Danaher Corporation (NYSE:DHR) has been downgraded to Hold in a statement by Zacks Investment Research earlier today.

Having a price of $82.89, Danaher Corporation (NYSE:DHR) traded -4.11% lower on the day. With the last close up 1.63% from the two hundred day average, compared with the S&P 500 Index which has increased 0.03% over the same period. Danaher Corporation has recorded a 50-day average of $86.21 and a two hundred day average of $81.56. Volume of trade was up over the average, with 8,816,984 shares of DHR changing hands over the typical 2,280,820

Zacks Investment Research has downgraded Danaher Corporation (NYSE:DHR) to Hold in a statement released on 4/21/2017.

On 4/20/2017, Vetr Inc. released a statement on Danaher Corporation (NYSE:DHR) upped the target price from $0.00 to $94.18 that suggested an upside of 0.14%.

Performance Chart

Danaher Corporation (NYSE:DHR)

With a total market value of $0, Danaher Corporation has price-earnings ratio of 22.70 with a one year low of $72.34 and a one year high of $102.79 .

A total of 20 analysts have released a report on Danaher Corporation. Nine analysts rating the company a strong buy, six analysts rating the company a buy, eight analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $104.22.

More About Danaher Corporation (NYSE:DHR)

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. As of December 31, 2016, Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *